Netflix Rides Hiked Price Target, Pfizer Drug Hits a Snag, and 3 More Hot Stocks

Netflix (NASDAQ:NFLX): Netflix has been awarded with a generous price target hike from MKM Partners, based on the firm’s view that the streaming service’s international subscriber totals will surprise; MKM’s thesis on Netflix is more focused on global mass penetration than on pricing in the U.S. Netflix, now trading just shy of $320, has been hit with a $370 price target by the firm.

NFLX 20131001